Drug Type Small molecule drug |
Synonyms SB 205952, SB-205952 |
Target |
Action inhibitors |
Mechanism Bacterial IRS inhibitors(Bacterial isoleucyl-tRNA synthetase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Staphylococcal Infections | Preclinical | United Kingdom | 02 Sep 1995 | |
Bacterial Infections | Discovery | United Kingdom | - |